# A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

> **NCT04902131** · PHASE1 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 95 (actual)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** A MENOPUR solution for injection in pre-filled pen, 600 IU/0.96 mL
- **DRUG:** A MENOPUR powder including solvent for solution for injection, 75 IU

## Key facts

- **NCT ID:** NCT04902131
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-02
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-08-15
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2022-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04902131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04902131, "A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04902131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*